Onkure Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
OnKure Therapeutics registers the resale of 2.9 million shares of Class A Common Stock issued in a private placement following its merger with Reneo Pharmaceuticals.